New drug shows promise in reducing painful sickle cell crises
NCT ID NCT04662931
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 38 times
Summary
This study looked at the safety of a drug called crizanlizumab in 140 Indian patients aged 16 and older with sickle cell disease who have had painful crises. The drug is meant to reduce the frequency of these crises. Researchers monitored serious side effects and other adverse events to ensure the treatment is safe for this population.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE (SCD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Guwahati, Assam, 781003, India
-
Novartis Investigative Site
Raipur, Chhattisgarh, 492099, India
-
Novartis Investigative Site
Kozhikode, Kerala, 673008, India
-
Novartis Investigative Site
Bhubaneswar, Odisha, 751003, India
-
Novartis Investigative Site
Hyderabad, Telangana, 500082, India
-
Novartis Investigative Site
Lucknow, Uttar Pradesh, 226014, India
-
Novartis Investigative Site
Kolkata, West Bengal, 700014, India
Conditions
Explore the condition pages connected to this study.